Le Lézard
Classified in: Science and technology, Business
Subjects: LAW, PLW

Hurom Wins Patent Infringement Ruling Against NUC(Kuvings) on Amazon in the U.S.


Sales Ban Enforced on NUC(Kuvings)'s Primary Juicer Models on Amazon

SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Hurom, a global leader in juicing technology as the pioneer of low-speed extraction methods, announced successful enforcement of its patent against NUC(Kuvings) on Amazon's U.S. platform. This action resulted in a sales ban on NUC(Kuvings)'s primary juicer models.

Since its founding in 1974, Hurom has dedicated over 50 years to provide customers with the latest innovations in juicing technology, including developing the world's first vertical screw juicer in 2005 and establishing the industry standard for vertical juicers. The company remains focused on promoting health through the introduction of new technology to foster the growth of the wellness culture.

Recently, Hurom has encountered increased instances of unauthorized use of its patent technology in global markets, such as China, the U.S., and Europe. To protect its core technology, Hurom announced a comprehensive global patent enforcement strategy earlier this year.

This recent case was resolved through Amazon's APEX (Amazon Patent Evaluation Express) process (APEX ID: 15060613361), resulting in a sales ban on the infringing products. As of July 11, 2024, Amazon's U.S. platform implemented a sales ban on five of NUC(Kuvings)'s main models, including the REVO830W, EVO820GM, C7000S, C7000W, and C7000P, distributed by over nine vendors, such as Kuvings USA and GlobalEcom. 

Amazon's APEX process starts with a report of suspected infringement, followed by a review from a neutral third-party evaluator. If a product is determined to infringe on a patent, it is subsequently removed from Amazon's listings.

Following this action, Hurom's intellectual property team has initiated further legal proceedings through the European Unified Patent Court (UPC) against infringing manufacturers and distributors. Additionally, the Korea Trade Commission (KTC) has launched an investigation into NUC(Kuvings) for alleged unfair trade practices related to patent infringement.

To support a healthier and fair global ecosystem, Hurom is committed to ongoing and proactive patent enforcement efforts.

Jaewon Kim, CEO of Hurom, stated, "We can no longer overlook the unauthorized use of Hurom's patented technology. Through decisive action, we will protect the healthy and fair ecosystem that both Hurom and our customers value. However, in line with Hurom's patent licensing policy, we are open to allowing genuine users access to our patented technology to support a shared commitment to wellness."


These press releases may also interest you

at 16:05
Hologic, Inc. announced today preliminary revenue results for its first fiscal quarter ended December 28, 2024. The Company expects to report total revenues of approximately $1,021.8 million, an increase of 0.9% compared to the prior year period,...

at 16:05
Exelixis, Inc. today announced its preliminary unaudited financial results for the fiscal year 2024, provided financial guidance for fiscal year 2025 and delivered an update on its business. Exelixis anticipates 2025 will be a year of clinical and...

at 16:05
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced its preliminary* fourth quarter and full year 2024 global net product revenues for ONPATTRO, AMVUTTRA, GIVLAARI, and OXLUMO. In addition, the Company provided 2025...

at 16:00
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") and certain of its...

at 16:00
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited ("Capri" or "the Company") and certain of its officers....

at 12:00
10x Genomics, Inc. , a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2024....



News published on and distributed by: